Neonatal Phototherapy Devices Market to Expand from US$ 110.4 Mn in 2025 - Persistence Market Research

The neonatal phototherapy devices market has experienced steady growth in recent years, driven by the rising prevalence of neonatal jaundice-a condition affecting approximately 60% of term and 80% of preterm newborns globally. This market plays a vital role in neonatal intensive care by offering non-invasive, light-based treatment to reduce elevated bilirubin levels in newborns.

In 2025, the global neonatal phototherapy devices market is estimated to reach US$ 110.4 million, with a compound annual growth rate (CAGR) of 4.3% expected to propel it to US$ 147.9 million by 2032. This growth is largely attributed to technological advancements in LED-based phototherapy systems, the increasing number of preterm births, and efforts to improve neonatal healthcare infrastructure in both developed and developing regions.

Phototherapy lamps, especially those utilizing high-intensity blue LED lights, represent the largest product segment. These devices offer reliable, efficient bilirubin reduction and are widely used in neonatal intensive care units (NICUs). Furthermore, North America leads the global market, holding a projected 40.2% share in 2025. This dominance is due to the region's advanced hospital infrastructure, early adoption of innovative neonatal care technologies, and strong regulatory support for infant health.

✅Get a Sample Copy of Research Report (Use Corporate Mail id for Quick Response): https://www.persistencemarketresearch.com/samples/35192

Key Highlights from the Report

➤ The global neonatal phototherapy devices market is projected to reach US$ 147.9 million by 2032.

➤ North America dominates the market due to advanced infrastructure and early technology adoption.

➤ The phototherapy lamps segment accounts for the highest revenue share.

➤ Rising demand for home-use and portable phototherapy devices is fueling market expansion.

➤ Strategic partnerships, like NeoLight and ANT Neuro, are shaping competitive dynamics.

➤ Innovations in LED and hybrid incubator systems are creating new growth avenues.

How is the Neonatal Phototherapy Devices Market Segmented by Product, Application, and End-User?

By Product Type:
The market is primarily segmented into phototherapy lamps, fiber optic phototherapy devices, and compact, portable systems. Phototherapy lamps, especially those using LED technology, dominate due to their superior energy efficiency, longer life span, and clinically proven efficacy. Fiber optic devices, though less dominant, are gaining popularity for their flexibility and reduced heat emission-particularly useful for at-home care or in resource-limited settings.

By Application:
The overwhelming majority of neonatal phototherapy devices are used for neonatal jaundice management, accounting for an estimated 83.2% of the market in 2025. Other emerging applications include the treatment of infantile hemangiomas and dermatological conditions like eczema. However, jaundice remains the central focus, especially with increasing incidences among preterm and low birth-weight infants.

By End-User:
Hospitals and NICUs remain the primary end-users, benefiting from large-scale, high-intensity phototherapy setups. However, there is growing adoption in home care settings due to advancements in compact and wearable devices. This shift aligns with trends in decentralized healthcare and increasing parental awareness about early jaundice management.

Which Regions Are Leading the Neonatal Phototherapy Devices Market and Why?

North America:
North America is expected to maintain its market dominance, holding 40.2% of the global share by 2025. The region benefits from robust neonatal care infrastructure, high healthcare expenditure, and strong government initiatives for maternal and child health. Companies such as NeoLight and GE Healthcare are leading innovation through partnerships, like NeoLight's collaboration with Premier Inc. and ANT Neuro, enhancing access to state-of-the-art devices.

East Asia and Asia-Pacific:
East Asia, particularly Japan, South Korea, and China, is emerging as a strong growth market with a projected share of 18.3% by 2025. The region's demand is fueled by rising preterm birth rates, improving healthcare infrastructure, and government investment in neonatal care. Technological advances, such as wearable jaundice monitors and e-commerce-based medical device distribution, are further expanding access across rural and urban populations.

Meanwhile, countries like India, Indonesia, and the Philippines are focusing on cost-effective, portable phototherapy solutions, supported by public health initiatives. These markets represent future growth hotspots as governments ramp up investments in NICUs and maternal-infant health.

What Factors Are Driving Growth in the Neonatal Phototherapy Devices Market?

Market Drivers: Increasing Preterm Births Necessitating Advanced Phototherapy Solutions

The neonatal phototherapy devices market is primarily driven by the rising incidence of preterm births and neonatal jaundice. According to WHO, an estimated 15 million babies are born prematurely every year, many of whom are at risk of hyperbilirubinemia. This global health concern necessitates immediate and effective interventions.

LED phototherapy systems have revolutionized treatment with advantages such as high-intensity light, reduced energy consumption, and minimal heat emission. Devices like the Natus neoBLUE LED and GE Healthcare's Lullaby LED are at the forefront of clinical care. Furthermore, the integration of phototherapy with incubator systems, like Atom Medical's Dual Incu i, enhances convenience and reduces handling risks, making them increasingly popular in both developed and emerging markets.

Market Restraints: Limited Access to Neonatal Care in Low-Resource Settings

Despite promising technological advancements, several challenges hamper widespread adoption in lower-income regions. Chief among them is the lack of access to NICU facilities, trained personnel, and essential phototherapy equipment in rural and underserved areas. These gaps in healthcare delivery contribute to delayed diagnosis and treatment of neonatal jaundice, leading to preventable complications such as kernicterus.

Additionally, the high upfront cost of advanced phototherapy systems limits their deployment in public hospitals with constrained budgets. In some regions, inconsistent electricity supply and maintenance issues also affect device reliability, further restraining market penetration. Bridging these disparities requires targeted policy intervention, international aid, and innovation in low-cost, portable phototherapy solutions.

✅Request for Customization of the Research Report: https://www.persistencemarketresearch.com/request-customization/35192

Market Opportunities: Government Investments Boost Neonatal Care Infrastructure

Emerging economies present significant opportunities for market expansion as governments and NGOs invest in maternal and child health. India's National Health Mission and Brazil's Rede Cegonha are examples of large-scale initiatives that are expanding NICU infrastructure and improving neonatal survival rates.

These public health programs are creating fertile ground for the adoption of neonatal phototherapy devices. Additionally, partnerships with non-profits and global health organizations are facilitating the distribution of affordable, durable phototherapy devices, such as D-Rev's Brilliance Pro. Market players who align with these initiatives and offer scalable, easy-to-maintain solutions are poised to capture substantial market share in the coming years.

Frequently Asked Questions about the Neonatal Phototherapy Devices Market

➤ How Big is the Neonatal Phototherapy Devices Market in 2024?

➤ Who are the Key Players in the Global Neonatal Phototherapy Devices Market?

➤ What is the Projected Growth Rate of the Neonatal Phototherapy Devices Market?

➤ What is the Market Forecast for the Neonatal Phototherapy Devices Market through 2032?

➤ Which Region is estimated to dominate the Neonatal Phototherapy Devices Market during the Forecast Period?

Company Insights: Leading Players in the Neonatal Phototherapy Devices Market

✦ GE HealthCare
✦ Natus Medical Incorporated
✦ NeoLight
✦ Atom Medical Corp
✦ Drägerwerk AG & Co. KGaA
✦ Phoenix Medical Systems
✦ D-Rev
✦ MTTS

These players are at the forefront of innovation, focusing on energy efficiency, portability, and integration with other neonatal care systems.

Recent Developments in the Neonatal Phototherapy Devices Market

■ NeoLight announced a Breakthrough Technology agreement with Premier, Inc. to supply Skylife Neonatal Phototherapy Systems across U.S. NICUs.

■ NeoLight also entered an exclusive U.S. distribution agreement with ANT Neuro, expanding access to the nëo CFM cerebral monitoring system.

Conclusion

The global neonatal phototherapy devices market is poised for significant growth, projected to rise from US$ 110.4 million in 2025 to US$ 147.9 million by 2032, at a CAGR of 4.3%. Key drivers include increasing incidences of neonatal jaundice, growing demand for non-invasive and portable treatment options, and substantial public health investments aimed at enhancing neonatal care.

Leading players like GE Healthcare, NeoLight, and Natus Medical are reshaping the landscape with next-generation phototherapy technologies. Simultaneously, strategic government and NGO initiatives are improving access to essential neonatal healthcare in low- and middle-income regions.

As the healthcare sector continues to prioritize advanced, safe, and cost-effective neonatal solutions, the neonatal phototherapy devices market is set to evolve rapidly-unlocking new opportunities and improving outcomes for millions of newborns worldwide.

Contact Us:

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.